Try our Advanced Search for more refined results

URL PHARMA, INC. et al v. RECKITT BENCKISER INC.

  1. November 29, 2017

    Reckitt, Generics Makers Settle Mucinex Antitrust Case

    Reckitt Benckiser Inc. has reached a settlement with a generic-drug maker that had accused the British company of unfairly cutting out competition for an extended-release version of Mucinex by violating a patent infringement settlement agreement they'd struck, according to a judgment Tuesday ending the Pennsylvania federal court case.

  2. April 20, 2016

    Reckitt Ducks Drug Supply Order In Mucinex Antitrust Case

    Reckitt Benckiser does not immediately have to start supplying a version of its Mucinex cough and cold medicine to a generic drugmaker pursuing antitrust and contract claims against Reckitt, a Pennsylvania federal judge ruled Wednesday, citing concerns about drug quality standards.

  3. October 02, 2015

    Reckitt Loses Reconsideration Bid In Mucinex Antitrust Row

    Reckitt Benckiser Inc.'s bid to escape an antitrust and contract breach lawsuit filed by URL Pharma Inc. over a right to sell generic Mucinex has again fallen short, with a Pennsylvania federal judge refusing to reconsider an earlier decision.

  4. September 10, 2015

    Reckitt Launches Counterclaims In Mucinex Antitrust Suit

    Reckitt Benckiser Inc. struck back Wednesday at an antitrust and breach of contract suit URL Pharma Inc. and other drugmakers filed over a right to sell generic Mucinex, telling a federal court the parties didn't have an enforceable contract under New York law.

  5. August 26, 2015

    Reckitt Must Face Majority Of Mucinex Monopoly Claims

    A Pennsylvania federal judge kept intact Tuesday the majority of URL Pharma Inc.'s antitrust and contract breach suit against Reckitt Benckiser Inc. over a right to sell generic Mucinex, saying the plaintiffs sufficiently alleged Reckitt acted anticompetitively within the relative market.